MTSS1 and chronic myelogenous leukemia, BCR-ABL1 positive: Confirming the tumor-suppressive role of Mtss1 in CML, its experimental re-expression inhibited colony formation in semi-solid media and decreased leukemic burden in recipient mice [26].